Clinical significance of dornase alfa (Pulmozyme) in complex therapy of early age children suffering cystic fybrosis
- 作者: Shelepneva NE1, Kashirskaya NY.1, Sherman VD1, Kapranov NI1, Shelepneva NE1, Kashirskaya NY.1, Sherman VD1, Kapranov NI1
-
隶属关系:
- 期: 编号 6 (2009)
- 页面: 99-103
- 栏目: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/276585
- ID: 276585
如何引用文章
全文:
详细
作者简介
N Shelepneva
N Kashirskaya
V Sherman
N Kapranov
N Shelepneva
N Kashirskaya
V Sherman
N Kapranov
参考
- Капранов Н.И., Каширская Н.Ю., Толстова В.Д. Муковисцидоз. Ранняя диагностика и лечение. М., 2008. С. 104.
- Koch C, Hoiby NS. Pathogenesis of cystic fibrosis. Lancet 1993;341:1065-69.
- Kirchner KK, Wagener JS, Khan TZ, et al. Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis. Am J Respir Crit Care Med 1996;154(5):1426-29.
- Massion PP, Inou H, Richman-Eisenstat J, et al. Novel Pseudomonas product stimulates interlrukin-8 production in airway epithelial cells in vitro. J Clin Invest 1994;93:26-32.
- Ruef C, Jefferson DM, Schlegel-Hauter SE, et al. Regulation of cytokine secretion by cystic fibrosis airway epithelial cells. Eur Respir J 1993;6:1429-36.
- Shmarina GV, Pukhalsky AL, Kokarovtseva SN, et al. Tumor necrosis factor-alfa/interleukin-10 balance in normal and cystic fibrosis children. Mediators of Inflammation 2001;10:191-97.
- Berger M, Sorensen RU, Tosi MF, et al. Complement receptor expression on neutrophils at an inflammatory site the pseudomonas-infected lung in cystic fibrosis. J Clin Invest 1989;84:1303-13.
- Regnis JA, Robinson M, Baileu DL. Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med 1994;150:66-71.
- Ratjen F, Paul K, van Koningsbruggen S, et al. DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha. Pediatr Pulmonol 2005;39(1):1-4.
- Frederiksen B, Pressler T, Hansen A, et al. Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis. Acta Paediatr 2006;95(9):1070-74.
- Капранов Н.И., Воронкова А.Ю., Каширская Н.Ю. и др. Комплексное лечение муковисцидоза у детей раннего возраста: клиническое значение дорназы-альфа // Клиницист. 2007. № 2. С. 60-65.
- Богданова Т.А., Каширская Н.Ю., Толстова В.Д. и др. Клиническая эффективность и безопасность пульмозима (дорназа альфа) у детей раннего возраста, больных муковисцидозом // Российский вестник перинатологии и педиатрии. 2008. Т. 53. № 4. С. 35-42.